Valink Therapeutics Appoints Martin D. Williams as Board Chair, Names Scientific Advisory Board

Valink Therapeutics, a biopharmaceutical company focused on the discovery and development of bispecific antibody-drug conjugates (bsADCs) to treat cancer and other diseases, has announced the appointment of Martin D. Williams as Chair of its Board of Directors. Additionally, the company…









